[Music] [Applause] [Music] 17 years. That's how long it takes for clinically important research findings to make their way into widespread healthc care practice. 17 years.And for many findings, it doesn't happen at all. You could say that research is lost in translation. Ideas, discoveries with the potential of transforming lives remain buried in books and journals, never reaching the hands of the people who need them the most.This 17-year gap between practice and research, it's not just a statistic to me, ...

Core Viewpoint - NeuroOne Medical Technologies Corporation has received FDA clearance for its OneRF Trigeminal Nerve Ablation System, which offers a minimally invasive alternative for treating trigeminal neuralgia, a chronic pain condition affecting approximately 150,000 people annually in the U.S. [1][2] Group 1: Product and Technology - The OneRF Trigeminal Nerve Ablation System utilizes a proprietary RF generator platform to create radiofrequency lesions for pain treatment and functional neurosurgical procedures [1][2] - This system features a unique multi-contact RF probe that allows for precise localization and tailored ablation of nerve tissue, enhancing safety and accuracy during procedures [3] - The technology aims to reduce procedural time, improve patient comfort, and enhance overall patient safety [3] Group 2: Market Potential and Strategy - The company plans a limited commercial launch of the OneRF system in the fourth quarter of 2025, with expectations to generate revenues from trigeminal nerve ablation by late 2025 [1][4] - NeuroOne's technology platform has potential applications across various neurological disorders and pain management functions, including lower back pain [4] - Current users of the OneRF brain ablation system may also adopt the nerve ablation procedures, justifying further investment in the technology [4] Group 3: Company Overview - NeuroOne Medical Technologies Corporation focuses on developing minimally invasive solutions for various neurological disorders, including epilepsy and chronic pain [5] - The company is exploring additional therapeutic applications, such as treatments for depression, mood disorders, and high blood pressure [5]

Cancer Care Crisis & Communication Breakdown - The cancer care system faces a communication crisis leading to unnecessary patient suffering [1] - Up to 70% of cancer patients don't disclose their use of integrative therapies due to fear [1] - While up to 66% of oncologists believe integrative approaches are beneficial, many hesitate to discuss them due to time constraints, limited training, and uncertainty about the evidence [1] Integrative Oncology & Its Benefits - Integrative oncology, using evidence-based practices like acupuncture, massage, meditation, and yoga alongside conventional treatments, can empower patients [1] - Integrative oncology improves well-being and quality of life in up to 65% of patients [2] - Hospitals with integrative oncology involvement have improved five-year overall survival odds [2] Call to Action & Solutions - Implementing structured conversations about integrative oncology at diagnosis is crucial [2] - Training oncologists to discuss pain management, emotional well-being, and whole-person care is essential [2] - Healthcare providers should utilize existing clinical guidelines from ASCO and the Society of Integrative Oncology to manage side effects [2]